321 related articles for article (PubMed ID: 34487163)
1. Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study.
Malagù M; Vitali F; Brieda A; Cimaglia P; De Raffele M; Tazzari E; Musolino C; Balla C; Serenelli M; Cultrera R; Rapezzi C; Bertini M
Europace; 2022 Mar; 24(3):413-420. PubMed ID: 34487163
[TBL] [Abstract][Full Text] [Related]
2. Proposal for a Novel Score to Determine the Risk of Cardiac Implantable Electronic Device Infection.
Calderón-Parra J; Sánchez-Chica E; Asensio-Vegas Á; Fernández-Lozano I; Toquero-Ramos J; Castro-Urda V; Royuela-Vicente A; Ramos-Martínez A
Rev Esp Cardiol (Engl Ed); 2019 Oct; 72(10):806-812. PubMed ID: 30340923
[TBL] [Abstract][Full Text] [Related]
3. Preoperative skin antiseptics for prevention of cardiac implantable electronic device infections: a historical-controlled interventional trial comparing aqueous against alcoholic povidone-iodine solutions.
Da Costa A; Tulane C; Dauphinot V; Terreaux J; Romeyer-Bouchard C; Gate-Martinet A; Levallois M; Isaaz K
Europace; 2015 Jul; 17(7):1092-8. PubMed ID: 25917024
[TBL] [Abstract][Full Text] [Related]
4. Prevention of Cardiac Implantable Electronic Device Infections: Single Operator Technique with Use of Povidone-Iodine, Double Gloving, Meticulous Aseptic/Antiseptic Measures and Antibiotic Prophylaxis.
Manolis AS; Melita H
Pacing Clin Electrophysiol; 2017 Jan; 40(1):26-34. PubMed ID: 27996097
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of the antibacterial envelope to prevent cardiac implantable electronic device infection in a high-risk population.
Chaudhry U; Borgquist R; Smith JG; Mörtsell D
Europace; 2022 Dec; 24(12):1973-1980. PubMed ID: 35989511
[TBL] [Abstract][Full Text] [Related]
6. Postoperative antibiotic prophylaxis in the prevention of cardiac implantable electronic device infection.
Madadi S; Kafi M; Kheirkhah J; Azhari A; Kiarsi M; Mehryar A; Fazelifar A; Alizadehdiz A; Emkanjoo Z; Haghjoo M
Pacing Clin Electrophysiol; 2019 Feb; 42(2):161-165. PubMed ID: 30575054
[TBL] [Abstract][Full Text] [Related]
7. Cardiac implantable electronic device infections: the enemy that lurks beneath the skin.
Margey R
J Long Term Eff Med Implants; 2010; 20(3):203-17. PubMed ID: 21395519
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis.
Polyzos KA; Konstantelias AA; Falagas ME
Europace; 2015 May; 17(5):767-77. PubMed ID: 25926473
[TBL] [Abstract][Full Text] [Related]
9. The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up.
Mittal S; Wilkoff BL; Kennergren C; Poole JE; Corey R; Bracke FA; Curnis A; Addo K; Martinez-Arraras J; Issa ZF; Redpath C; Moubarak J; Khelae SK; Boersma LVA; Korantzopoulos P; Krueger J; Lande JD; Morss GM; Seshadri S; Tarakji KG
Heart Rhythm; 2020 Jul; 17(7):1115-1122. PubMed ID: 32087357
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR
JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic Prophylaxis and Treatment in Early Cardiac Implantable Electronic Devices Infection.
Alshoubaki O; Al Darabaa Z; Odat O; Qubbaj A; Alhyari R; Alshare S; Ghanma I
Med Arch; 2021 Feb; 75(1):56-60. PubMed ID: 34012201
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of an absorbable antibiotic envelope for prevention of cardiac implantable electronic device infection.
Rennert-May E; Raj SR; Leal J; Exner DV; Manns BJ; Chew DS
Europace; 2021 May; 23(5):767-774. PubMed ID: 33554239
[TBL] [Abstract][Full Text] [Related]
13. Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score.
Ahmed FZ; Blomström-Lundqvist C; Bloom H; Cooper C; Ellis C; Goette A; Greenspon AJ; Love CJ; Johansen JB; Philippon F; Tarakji KG; Holbrook R; Sherfesee L; Xia Y; Seshadri S; Lexcen DR; Krahn AD
Europace; 2021 Sep; 23(9):1446-1455. PubMed ID: 33755136
[TBL] [Abstract][Full Text] [Related]
14. Infection control in implantation of cardiac implantable electronic devices: current evidence, controversial points, and unresolved issues.
Korantzopoulos P; Sideris S; Dilaveris P; Gatzoulis K; Goudevenos JA
Europace; 2016 Apr; 18(4):473-8. PubMed ID: 26516219
[TBL] [Abstract][Full Text] [Related]
15. Retrospective comparative analysis of cardiovascular implantable electronic device infections with and without the use of antibacterial envelopes.
Hassoun A; Thottacherry ED; Raja M; Scully M; Azarbal A
J Hosp Infect; 2017 Mar; 95(3):286-291. PubMed ID: 28131641
[TBL] [Abstract][Full Text] [Related]
16. Predictors of infection after "de novo" cardiac electronic device implantation.
Balla C; Brieda A; Righetto A; Vitali F; Malagù M; Cultrera R; Bertini M
Eur J Intern Med; 2020 Jul; 77():73-78. PubMed ID: 32127301
[TBL] [Abstract][Full Text] [Related]
17. Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope.
Mittal S; Shaw RE; Michel K; Palekar R; Arshad A; Musat D; Preminger M; Sichrovsky T; Steinberg JS
Heart Rhythm; 2014 Apr; 11(4):595-601. PubMed ID: 24333543
[TBL] [Abstract][Full Text] [Related]
18. The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection.
Qintar M; Zardkoohi O; Hammadah M; Hsu A; Wazni O; Wilkoff BL; Tarakji KG
Pacing Clin Electrophysiol; 2015 Feb; 38(2):240-6. PubMed ID: 25224666
[TBL] [Abstract][Full Text] [Related]
19. The BLISTER Score: A Novel, Externally Validated Tool for Predicting Cardiac Implantable Electronic Device Infections, and Its Cost-Utility Implications for Antimicrobial Envelope Use.
Maclean E; Mahtani K; Honarbakhsh S; Butcher C; Ahluwalia N; Dennis ASC; Creta A; Finlay M; Elliott M; Mehta V; Wijesuriya N; Shaikh O; Zaw Y; Ogbedeh C; Gautam V; Lambiase PD; Schilling RJ; Earley MJ; Moore P; Muthumala A; Sporton SCE; Hunter RJ; Rinaldi CA; Behar J; Martin C; Monkhouse C; Chow A
Circ Arrhythm Electrophysiol; 2024 Mar; 17(3):e012446. PubMed ID: 38258308
[TBL] [Abstract][Full Text] [Related]
20. Randomized Trial of Stand-Alone Use of the Antimicrobial Envelope in High-Risk Cardiac Device Patients.
Ellis CR; Greenspon AJ; Andriulli JA; Gould PA; Carillo RG; Kolek MJ; Donegan R; Amaral AP; Mittal S
Circ Arrhythm Electrophysiol; 2023 May; 16(5):e011740. PubMed ID: 36960716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
